Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
09/2009
09/09/2009CN100536839C Urea derivatives as integrin alpha 4 antagonists
09/08/2009US7585985 Substituted benzopyrans as selective estrogen receptor-beta agonists
09/08/2009US7585984 deuterated dianhydride monomer, d6-3,3',4,4'-biphenyltetracarboxylic dianhydride; excellent mechanical, thermal and optical properties, for high-power lasers used in particular when nuclear physics experiments are carried out; prepare the monomer by deuteration
09/08/2009US7585983 Alkylenedioxythiophenes and poly(alkylenedioxythiophenes) containing mesogenic groups
09/08/2009US7585891 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides
09/08/2009US7585860 Substituted oxazolidinones and their use in the field of blood coagulation
09/08/2009CA2334010C Novel peroxidase substrates and their use in catalyzed reporter deposition
09/08/2009CA2316388C Tetrahydrobenzindole derivative
09/08/2009CA2287558C Heterocyclic derivatives and their use as antithrombotic agents
09/03/2009WO2009108798A1 Method for treating pain syndrome and other disorders
09/03/2009WO2009106665A1 Double-labelling agents based on vinyl sulphone
09/03/2009WO2009106664A1 Single-labelling agents based on vinyl sulphone
09/03/2009WO2009058937A3 Heteroaryl ethers and processes for their preparation
09/03/2009US20090221763 Chemical Defunctionalization of Polymeric Alkylenedioxyheterocyclics
09/03/2009US20090221687 Tetracyclic Monoamine Reuptake Inhibitors for Treatment of Cns Diseases and Disorders
09/03/2009US20090221560 Pharmaceutical Formulation
09/03/2009US20090220420 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (pbr)
09/03/2009CA2716798A1 Tetrahydrofuropyridones
09/03/2009CA2712583A1 Tetrahydrothieno pyridines
09/02/2009EP2096110A1 Acridane-9-dithiocarboxylate derivatives for generating chemiluminescence with a peroxidase
09/02/2009EP2096104A1 Organic diamines as mGluR7 modulators
09/02/2009EP2094712A2 Compounds useful as protein kinase inhibitors
09/02/2009EP2094707A1 Heterobicyclic matrix metalloprotease inhibitors
09/02/2009EP2094706A2 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands
09/02/2009EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives
09/02/2009CN101522688A Novel dithiolopyrrolones and their therapeutical applications
09/02/2009CN101522687A Heterobicyclic thiophene compounds and methods of use
09/02/2009CN101519409A Method for preparing 3, 4-ethylenedioxythiophene
09/02/2009CN101519386A Large conductance calcium-activated K channel opener
09/01/2009CA2494528C Racemization and enantiomer separation of clopidogrel
09/01/2009CA2452432C Active ingredient combination for the pharmacological therapy of nicotine dependence
08/2009
08/27/2009WO2009105042A1 Thienothiophene derivatives
08/27/2009WO2009105041A1 Dithienothiophene derivatives
08/27/2009WO2009104819A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009WO2009104733A1 Organic electroluminescent device material and organic electroluminescent device
08/27/2009WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/27/2009WO2009104027A1 Therapeutic application of triciclic aromatic and saturated benzo(4,5)thieno-(2,3-d)pyrimidine derivates, as well as their therapeutically acceptable salts
08/27/2009WO2009104026A1 Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
08/27/2009WO2009086028A3 Carbazole-containing materials in phosphorescent light emitting diodes
08/27/2009US20090216027 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
08/27/2009US20090215787 Preparations of new polymorphic forms of varenicline tartrate
08/27/2009US20090214432 Radicals and Their Use As Paramagnetic Agents in a DNP Process
08/27/2009CA2715872A1 Benzodiazepine compound and pharmaceutical composition
08/27/2009CA2713184A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/26/2009EP2093228A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
08/26/2009EP1858898B1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use
08/26/2009CN101516891A Dihydrothieno pyrimidines as AKT protein kinase inhibitors
08/26/2009CN101514207A Method for preparing dithieno[3,4-b; 3',4'-d]thiophene
08/26/2009CN101514196A Thiophene derivative and application thereof
08/25/2009US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia
08/25/2009US7579477 Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof
08/25/2009US7579419 Superior in hole injecting property, making it unnecessary to add a strongly acidic dopant for enhancing hole injecting property; may be useful in flat panel display devices
08/25/2009US7579417 For example, { mu-( eta 5-2-Methyl-8-phenyl-3H-cyclopenta[a]naphth-3-yl)( eta 5-2,5-dimethyldithiophenocyclopentadien-7-yl)dimethylsilanediyl]dichiorozirconium; catalyst for (co)polymerizing olefins comprising from 2 to 20 carbon atoms
08/25/2009CA2538072C Amide-type carboxamide derivatives
08/20/2009WO2009102462A1 Thienopyrroles and pyrrolothiazoles as new therapeutic agents
08/20/2009WO2009102377A2 Antibiotic tetrahydro-beta-carboline derivatives
08/20/2009WO2009102031A1 Condensed polycyclic compound, condensed polycyclic polymer and organic thin film containing the compound or the polymer
08/20/2009WO2009101982A1 Fused ring compound, method for producing the same, polymer, organic thin film containing the compound and/or the polymer, and organic thin film device and organic thin film transistor each comprising the organic thin film
08/20/2009WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/20/2009WO2009074733A3 Addition salts of angiotensine-converting enzyme inhibitors with no donor acids, method for preparing same and pharmaceutical compositions containing same
08/20/2009US20090209609 Thienopyrroles and pyrrolothiazoles as new therapeutic agents
08/20/2009US20090209576 Pharmaceutical composition containing clopidogrel camphorsulfonate or polymorphic forms thereof
08/20/2009US20090209571 Phenanthrene derivatives as MPGES-1 inhibitors
08/20/2009US20090209559 Pharmaceutical compounds
08/20/2009US20090209534 Novel compounds and use of tetrahydropyridopyridothiophenes
08/20/2009US20090209531 used for treating metabolic, nervous sytsem and skin disorders,inflammatory diseases, obesity, cachexia, erectile dysfunction, neuropathic pain, or as antidepressants, anxiolytic and anticarcinogenic agents
08/20/2009CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/20/2009CA2707442A1 Antibiotic tetrahydro-beta-carboline derivatives
08/19/2009EP2090576A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
08/19/2009EP2090575A1 Processes and intermediates for the preparation of N4-phenyl-quinazoline-4-amine derivatives
08/19/2009EP2089396A1 A process for preparing (s)-(+)-clopidogrel base and its salts
08/19/2009EP2089385A2 Inhibitors of hepatitis c virus
08/19/2009EP2089382A1 Substituted diazepan compounds as orexin receptor antagonists
08/19/2009EP1648864A4 Photochromic diarylethene-containing coordination compounds and the production thereof
08/19/2009CN101511840A Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
08/19/2009CN101511832A Fused heterocyclic inhibitors of D-amino acid oxidase
08/19/2009CN101511354A Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders
08/19/2009CN101508669A Green synthesis of indole compounds
08/19/2009CN100528882C Spirotetrathiocarbamates and spirooxothiocarbamates
08/19/2009CN100528881C Fluorinated alkyl substituted-thieno[3,4-b]thiophene monomers and polymers therefrom
08/19/2009CN100528834C Pharmaceutical compounds
08/18/2009US7576224 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
08/18/2009US7576211 coupling 3-(piperidin-1-yl)propan-1-amine with intermediate methyl 6,7-dihydro-4-hydroxy-7-isopropyl-6-oxothieno-[2,3-b]pyridine-5-carboxylate to form 6,7-dihydro-4-hydroxy-7-isobutyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno[2,3-b]pyridine-5-carboxamide
08/18/2009US7576111 Substituted oxazolidinones and their use in the field of blood coagulation
08/18/2009US7576085 Imidazo[1,2-a]pyrazine compounds; cancers
08/18/2009US7576080 N-[3-(3-{[5-(4-Fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy}propoxy)phenyl]cyclopropanecarboxamide; PDE10 inhibitor; psychological, nervous system disorders; schizophrenia; cognition activators; drug abuse; antiepileptic agents; lupus; antitumor, -carcinogenic agents; hyperglycemica agents; sarcoidosis
08/18/2009CA2392030C Urea compounds having muscarinic receptor antagonist activity
08/18/2009CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity
08/18/2009CA2347853C Process for racemization of [2-(2-thienyl)ethylamino] (2-halogenophenyl)acetamides
08/18/2009CA2239282C Fused isoindolones as inhibitors of protein kinase c
08/13/2009WO2009099982A1 2-aminopyridine kinase inhibitors
08/13/2009WO2009099070A1 Organic semiconductor material
08/13/2009WO2009098142A1 Prasugrel salts with improved properties
08/13/2009US20090203879 Activated labeling reagents and methods for preparing and using the same
08/13/2009US20090203873 Conjugated polymers from substituted 3,4-propylenedioxythiophene, compositions, method of making, and use thereof
08/13/2009US20090203730 Bicyclic ppat inhibitors as antibacterial agents
08/13/2009US20090203729 Process for Producing High-Purity Prasugrel and Acid Addition Salt Thereof
08/13/2009US20090203716 Pyrimidine low molecular weight ligands for modulating hormone receptors
08/13/2009US20090203703 Thienopyrimidine Derivatives
08/13/2009US20090203524 Insecticidal Methods Using 4-Amino-5-chloro-thieno[2,3-d]-pyrimidine Compounds
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 214